Amyotrophic Lateral Sclerosis Treatment Market: A Prognostic Outlook on the $1 Billion Market by 203
The global amyotrophic lateral sclerosis (ALS) treatment market, valued at $662.3 million in 2022, is poised for substantial growth, projected to reach $1,038.94 million by 2032. Characterized by a devastating impact on nerve cells, ALS necessitates innovative treatments to address varying symptoms and progression r...